Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A discovery in how cells absorb substances provides insights into certain cancers and may be applied to therapeutic drugs.
Known as a carbon nanotube, the implant can detect cancer-associated proteins and alert a devise outside the body.
Researchers explore the relationship between gut bacteria and the body’s response to CAR-T therapy.
Similar to Legos, TIDA boronates can be assembled into tiny 3D pharmaceuticals—perfect for cancer therapies targeting small molecules.
The discovery that pancreatic cancers can be sustained by hyaluronic acid is challenging to translate into therapies. Here’s why.
New discoveries may show a way to save bone marrow cells and blood stem cells following chemotherapy.
There is more to cancer immunotherapy than cytotoxic T cells.
New clues help explain why only 10-15% of ovarian cancer patients respond favorably to immune checkpoint inhibitor therapy.
In animal studies, introducing intestinal bacteria can promote anti-tumor immunity in the colon.
Immunotherapy response tends to follow a pattern, while resistance looks different from patient to patient.
Damon Runyon Cancer Research Foundation scientists work to develop drugs for people with KRAS-driven cancers.
Among babies with Beckwith-Wiedemann Syndrome, scientist are identifying which genetic changes are more likely to cause cancers.
In animal studies, calorie-restricted diets slowed pancreatic tumor growth more than did high-fat ketogenic diets.
P-NET is a “biologically informed deep learning model” capable of guessing a prostate cancer patient’s disease state.
Damon Runyon Cancer Research Foundation Fellows are mapping the genetics of DNA repair, with implications for cancer research.
An estrogen receptor known as ERα plays a critical role in more than 70% of breast cancers.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.